Market Overview

12 Biggest Mid-Day Losers For Friday

  • Cellect Biotechnology Ltd. - American Depositary Shares (NASDAQ: APOP) fell 29.5 percent to $4.31. Cellect Biotechnology shares surged Thursday after the company disclosed that it has received a notice of allowance from the US Patent Office protecting its technology in multiple key indications.
  • Uranium Resources, Inc. (NASDAQ: URRE) shares dropped 25.2 percent to $2.35 after the company reported the pricing of $9.7 million public offering.
  • Skyline Medical Inc (NASDAQ: SKLN) shares declined 19.5 percent to $2.27. Skyline Medical priced its stock and warrant offering for gross proceeds of $3.9 million.
  • Marinus Pharmaceuticals Inc (NASDAQ: MRNS) shares fell 15.9 percent to $1.18. Marinus Pharmaceuticals shares have declined 75.99 percent over the past 52 weeks, while the S&P 500 index has climbed 20.11 percent in the same period.
  • Inventure Foods Inc (NASDAQ: SNAK) declined 12.2 percent to $6.39. DA Davidson downgraded Inventure Foods from Buy to Neutral and lowered the price target from $10.00 to $8.00.
  • Ryerson Holding Corp (NYSE: RYI) dropped 9.2 percent to $12.30. Ryerson projects Q4 loss of $14 million to $11 million including LIFO expense.
  • GameStop Corp. (NYSE: GME) dropped 8.3 percent to $22.66. GameStop slashed its comparable sales guidance for the fourth quarter and full year after it reported “disappointing” holiday sales on industry weakness, pricing pressure and lower store traffic.
  • Biocept Inc (NASDAQ: BIOC) shares fell 6.6 percent to $1.99. Biocept shares have dropped 55.35 percent over the past 52 weeks, while the S&P 500 index has climbed 20.11 percent in the same period.
  • Infosys Ltd ADR (NYSE: INFY) shares declined 5.4 percent to $14.43. Infosys posted Q3 earnings of $0.24 per share on revenue of $2.55 billion.
  • MYOS RENS Technology Inc (NASDAQ: MYOS) shares fell 4 percent to $3.60 after dropping 45.01 percent on Thursday.
  • Actuant Corporation (NYSE: ATU) dropped 3 percent to $26.05. RBC Capital downgraded Actuant from Outperform to Sector Perform.
  • Alamos Gold Inc (US) (NYSE: AGI) slipped around 3 percent to $8.15. Credit Suisse downgraded Alamos Gold from Outperform to Neutral.

Latest Ratings for APOP

Apr 2017Rodman & RenshawReiteratesBuy
Nov 2016Rodman & RenshawInitiates Coverage OnBuy

View More Analyst Ratings for APOP
View the Latest Analyst Ratings

Posted-In: Mid-Day LosersNews Movers & Shakers Intraday Update Markets Analyst Ratings


Related Articles (AGI + APOP)

View Comments and Join the Discussion!

Latest Ratings

INTUMorgan StanleyMaintains245.0
View the Latest Analytics Ratings
Don't Miss Out!
Join Our Newsletter
Subscribe to:
Trader Essentials
Get pre-market outlook, mid-day update and after-market roundup emails in your inbox.
Market in 5 Minutes
Everything you need to know about the market - quick & easy.
Daily Analyst Rating
A summary of each day’s top rating changes from sell-side analysts on the street.
Thank You
for registering for Benzinga’s newsletters and alerts.
• The Daily Analysts Ratings email will be received daily between 7am and 10am.
• The Market in 5 Minutes email will be received daily between 7am and 8am.
• The Fintech Focus email will be received every Friday between 2pm and 5pm.

USD/JPY Edges Down

Tesla Will Start Charging Customers 'A Small Fee' For Heavy Users Of Its Supercharging Station